Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / Ordinary Shares, nominal value EUR0.05 per share
-
Shares outstanding
-
95,490,450
-
Total 13F shares
-
6,601,328
-
Share change
-
+476,865
-
Total reported value
-
$238,170,032
-
Price per share
-
$36.08
-
Number of holders
-
40
-
Value change
-
+$18,429,242
-
Number of buys
-
27
-
Number of sells
-
23
Institutional Holders of Cellectis S.A. - Ordinary Shares, nominal value EUR0.05 per share (CLLS) as of Q2 2015
As of 30 Jun 2015,
Cellectis S.A. - Ordinary Shares, nominal value EUR0.05 per share (CLLS) was held by
40 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,601,328 shares.
The largest 10 holders included
FMR LLC, ORBIMED ADVISORS LLC, BlackRock Advisors LLC, JPMORGAN CHASE & CO, FRANKLIN RESOURCES INC, LAZARD ASSET MANAGEMENT LLC, Hudson Bay Capital Management LP, PERCEPTIVE ADVISORS LLC, GLG LLC, and PICTON MAHONEY ASSET MANAGEMENT.
This page lists
40
institutional shareholders reporting positions in this security
for the Q2 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.